Posts by: admin

Researchers at the Medical College of Georgia at Augusta University found a specific protein that seems to cause abnormal blood vessel growth in pulmonary arterial hypertension (PAH). The protein, called galectin-3, or ... Read more

June 22, 2016June 22, 2016

Vibativ Potent Against Difficult-to-Treat Bacteria, Including MRSA

News

The drug Vibativ could be effective against hard-to-treat bacteria, according to a study presented at the American Society of Microbiology (ASM) Microbe 2016 Conference, June 16 – 20, in Boston. Developed ... Read more

June 17, 2016June 17, 2016

Grazax for Childhood Asthma Nuetralizes Pollen, Could Hinder Disease Progression

Asthma, News

Results of the GAP (Grazax Asthma Prevention) trial, the largest study ever staged to examine allergy symptoms and immune system reactions in children, were revealed at the 2016 Annual Congress of the European Academy ... Read more

May 26, 2016May 26, 2016

Lung Cancer Drug Alecensa Shows Superior to Crizotinib, Study Indicates

News

The biotechnology company Genentech recently announced that its product Alecensa (alectinib) was superior in reducing disease worsening risk or death in a specific type of lung cancer, compared to treatment with crizotinib. Researchers measured the ... Read more

April 20, 2016April 20, 2016

Small Protein M10 Could Help Prevent Lung Fibrosis, According to Animal Study

Idiopathic Pulmonary Fibrosis, News, Scleroderma

A new study from researchers in South Carolina report that a small protein called M10 peptide might prevent fibrosis (scarring) in people with systemic sclerosis (SSc). M10 could be especially useful for ... Read more

April 12, 2016April 12, 2016

European Union Approves Giotrif (Afatinib) for Lung Squamous Cell Carcinoma

Lung Cancer, News

The European Union (EU) approved Giotrif (afatinib) on April 8 for the treatment of advanced squamous cell carcinoma (SqCC) of the lung in people for whom the disease has progressed despite treatment ... Read more

April 8, 2016April 8, 2016

Search for COPD, IPF and Asthma Treatments Could Benefit from Immune System Suppression Research

Asthma, COPD, Idiopathic Pulmonary Fibrosis, News

A collaborative study led by Weill Cornell Medicine investigators suggests that starving the immune system might lead to treatments for lung diseases, including chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), ... Read more

March 18, 2016March 23, 2016

Study Finds IPF Patients Should Continue Pirfenidone Use Even as Disease Progresses

Idiopathic Pulmonary Fibrosis, News

An international group of researchers addressed an important clinical question about idiopathic pulmonary fibrosis (IPF) — Should people with IPF continue treatment with pirfenidone (Esbriet) if their disease meaningfully worsens? ... Read more

March 15, 2016March 16, 2016

For Previously Treated Non-Small-Cell Lung Cancer, Atezolizumab Seems to Be More Effective than Docetaxel, Report Shows

Lung Cancer, News

A recent Phase 2 clinical trial demonstrated that the cancer treatment atezolizumab was more effective compared to docetaxel at improving survival in patients with previously treated non-small-cell lung cancer (NSCLC). The research ... Read more

March 3, 2016March 16, 2016

Key Cause of Pulmonary Fibrosis May Be Linked to Harmful Macrophages

Idiopathic Pulmonary Fibrosis, News

Researchers at the University of Alabama at Birmingham (UAB) published a new report linking macrophages to pulmonary fibrosis (PF). Macrophages are cells that engulf toxins and harmful molecules, but in pulmonary ... Read more